Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36 | 105 | 108 | 188 | 129 |
| Receivables | 159 | 92 | N/A | N/A | N/A |
| TOTAL | $197 | $203 | $117 | $198 | $137 |
| Non-Current Assets | |||||
| PPE Net | 300 | 118 | 60 | 58 | 27 |
| Intangibles | 674 | 674 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 8 | 80 | 0 | 0 |
| TOTAL | $974 | $800 | $140 | $58 | $27 |
| Total Assets | $1,170 | $1,002 | $258 | $256 | $164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 139 | 113 | 19 | 12 | 35 |
| Accrued Expenses | 34 | 22 | 9 | 6 | 5 |
| TOTAL | $1,137 | $1,181 | $751 | $610 | $781 |
| Non-Current Liabilities | |||||
| Long Term Debt | 310 | 322 | 80 | N/A | N/A |
| TOTAL | $310 | $322 | $80 | $N/A | $N/A |
| Total Liabilities | $1,446 | $1,503 | $831 | $610 | $781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 590 | 484 | 474 | 459 | 459 |
| Common Shares | 1,104 | 948 | 46 | 919 | 869 |
| Retained earnings | -14,528 | -13,884 | -13,618 | -13,407 | -13,259 |
| Other shareholders' equity | -8 | -2 | 1 | 9 | 4 |
| TOTAL | $-276 | $-501 | $-573 | $-354 | $-616 |
| Total Liabilities And Equity | $1,170 | $1,002 | $257 | $256 | $164 |